Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

Kristen Gryskevich, 51, found weight to be a struggle throughout her life, but when she gave birth to her two boys in 2001 ...

Here's where the company and its stock stand now. You may have heard of Novo Nordisk's Ozempic and Wegovy, as well as Eli Lilly's Mounjaro and Zepbound. These are currently the dominant brand-name GLP ...